Search research articles
Contact Us
Filters
Showing results (11-20 of 992) with videos related to
Page
of 100
Sort By:
Pharmacogenetics
|
September 2, 1999
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese
T Katoh, H Inatomi, M Yang, et al.
Pharmacogenetics
|
September 2, 1999
The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
O Spigset, S Hägg, E Söderström, et al.
Pharmacogenetics
|
January 14, 2000
The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6
R Bachus, U Bickel, T Thomsen, et al.
Pharmacogenetics
|
January 14, 2000
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
A Gaedigk, R R Gotschall, N S Forbes, et al.
Pharmacogenetics
|
January 14, 2000
Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity
S A Salama, S Z Abdel-Rahman, C H Sierra-Torres, et al.
Pharmacogenetics
|
January 14, 2000
Characterization of a novel variant (S145C/L311V) of 3alpha-hydroxysteroid/dihydrodiol dehydrogenase in human liver
T Kume, H Iwasa, H Shiraishi, et al.
Pharmacogenetics
|
September 7, 2000
Genetic variation in in-vitro cytokine-induced production of nitric oxide by murine peritoneal macrophages
Z Zídek, D Franková, M Boubelík
Pharmacogenetics
|
September 7, 2000
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours
S Ramachandran, P R Hoban, F Ichii-Jones, et al.
Pharmacogenetics
|
April 26, 2000
Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity
A D Kashuba, A N Nafziger, G L Kearns, et al.
Pharmacogenetics
|
April 26, 2000
Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese
W Liu, N Gu, G Feng, et al.
Page
of 100
Search research articles
Search
Showing results (11-20 of 992) with videos related to
Sort By:
Page
of 100
Pharmacogenetics
|
September 2, 1999
Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese
T Katoh, H Inatomi, M Yang, et al.
Pharmacogenetics
|
September 2, 1999
The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
O Spigset, S Hägg, E Söderström, et al.
Pharmacogenetics
|
January 14, 2000
The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6
R Bachus, U Bickel, T Thomsen, et al.
Pharmacogenetics
|
January 14, 2000
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
A Gaedigk, R R Gotschall, N S Forbes, et al.
Pharmacogenetics
|
January 14, 2000
Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity
S A Salama, S Z Abdel-Rahman, C H Sierra-Torres, et al.
Pharmacogenetics
|
January 14, 2000
Characterization of a novel variant (S145C/L311V) of 3alpha-hydroxysteroid/dihydrodiol dehydrogenase in human liver
T Kume, H Iwasa, H Shiraishi, et al.
Pharmacogenetics
|
September 7, 2000
Genetic variation in in-vitro cytokine-induced production of nitric oxide by murine peritoneal macrophages
Z Zídek, D Franková, M Boubelík
Pharmacogenetics
|
September 7, 2000
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours
S Ramachandran, P R Hoban, F Ichii-Jones, et al.
Pharmacogenetics
|
April 26, 2000
Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity
A D Kashuba, A N Nafziger, G L Kearns, et al.
Pharmacogenetics
|
April 26, 2000
Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese
W Liu, N Gu, G Feng, et al.
Page
of 100